Apaf-1 deficiency and neural tube closure defects are found in fog mice

被引:69
作者
Honarpour, N
Gilbert, SL
Lahn, BT
Wang, XD
Herz, J [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA
[3] Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA
[4] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA
[5] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA
关键词
spina bifida; neural development; apoptosis; caspase; cell death;
D O I
10.1073/pnas.171283198
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The forebrain overgrowth mutation (fog) was originally described as a spontaneous autosomal recessive mutation mapping to mouse chromosome 10 that produces forebrain defects, facial defects, and spina bifida. Although the fog mutant has been characterized and available to investigators for several years, the underlying mutation causing the pathology has not been known. Because of its phenotypic resemblance to apoptotic protease activating factor-1 (Apaf-1) knockout mice, we have investigated the possibility that the fog mutation is in the Apaf-1 gene. Allelic complementation, Western blot analysis, and caspase activation assays indicate that fog mutant mice lack Apaf-1 activity. Northern blot and reverse transcription-PCR analysis show that Apaf-1 mRNA is aberrantly processed, resulting in greatly reduced expression levels of normal Apaf-1 mRNA. These findings are strongly suggestive of the fog mutation being a hypomorphic Apaf-1 defect and implicate neural progenitor cell death in the pathogenesis of spina bifida-a common human congenital malformation. Because a complete deficiency in Apaf-1 usually results in perinatal lethality and fog/fog mice more readily survive into adulthood, these mutants serve as a valuable model with which apoptotic cell death can be studied in vivo.
引用
收藏
页码:9683 / 9687
页数:5
相关论文
共 18 条
[1]   Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development [J].
Cecconi, F ;
Alvarez-Bolado, G ;
Meyer, BI ;
Roth, KA ;
Gruss, P .
CELL, 1998, 94 (06) :727-737
[2]  
DeSesso JM, 1999, AM J MED GENET, V87, P143, DOI 10.1002/(SICI)1096-8628(19991119)87:2<143::AID-AJMG6>3.0.CO
[3]  
2-J
[4]   Differential requirement for Caspase 9 in apoptotic pathways in vivo [J].
Hakem, R ;
Hakem, A ;
Duncan, GS ;
Henderson, JT ;
Woo, M ;
Soengas, MS ;
Elia, A ;
de la Pompa, JL ;
Kagi, D ;
Khoo, W ;
Potter, J ;
Yoshida, R ;
Kaufman, SA ;
Lowe, SW ;
Penninger, JM ;
Mak, TW .
CELL, 1998, 94 (03) :339-352
[5]  
Harris BS, 1997, TERATOLOGY, V55, P231, DOI 10.1002/(SICI)1096-9926(199704)55:4<231::AID-TERA3>3.0.CO
[6]  
2-3
[7]   Adult Apaf-1-deficient mice exhibit male infertility [J].
Honarpour, N ;
Du, CY ;
Richardson, JA ;
Hammer, RE ;
Wang, XD ;
Herz, J .
DEVELOPMENTAL BIOLOGY, 2000, 218 (02) :248-258
[8]   Mouse models for neural tube closure defects [J].
Juriloff, DM ;
Harris, MJ .
HUMAN MOLECULAR GENETICS, 2000, 9 (06) :993-1000
[9]   Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking Caspase 9 [J].
Kuida, K ;
Haydar, TF ;
Kuan, CY ;
Gu, Y ;
Taya, C ;
Karasuyama, H ;
Su, MSS ;
Rakic, P ;
Flavell, RA .
CELL, 1998, 94 (03) :325-337
[10]   Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice [J].
Kuida, K ;
Zheng, TS ;
Na, SQ ;
Kuan, CY ;
Yang, D ;
Karasuyama, H ;
Rakic, P ;
Flavell, RA .
NATURE, 1996, 384 (6607) :368-372